Health

Molbio & UE LifeSciences Partner to Expand iBreastExam Globally for Early Breast Cancer Detection


Molbio Diagnostics has announced a strategic global collaboration with UE LifeSciences to expand the reach of iBreastExam, a radiation-free, painless, and FDA-cleared breast cancer screening device, to more than 50 countries across Asia, Africa, and beyond. This partnership represents a major step forward in making early detection accessible to millions of women who face barriers to traditional screening methods.

Breast cancer remains the leading cancer among women worldwide, and late detection is one of the most significant factors contributing to mortality. By combining Molbioโ€™s extensive global distribution network with UE LifeSciencesโ€™ innovative technology, this collaboration aims to transform the landscape of breast cancer screening in low- and middle-income regions.

iBreastExam is a portable, battery-operated point-of-care device that can identify breast lumps in minutes without pain, radiation, or the need for specialized infrastructure. Using advanced sensor technology, it automates physical examination, ensuring accuracy without requiring interpretation from the user. With cloud-enabled storage for seamless follow-up, it is designed for use in primary healthcare settings, outreach programs, and mass screening campaigns, particularly in communities where access to mammograms is limited or non-existent.

Mihir Shah, Founder and CEO of UE LifeSciences, emphasized the importance of this initiative, highlighting that Molbioโ€™s strong market presence and experienced team will help amplify their shared mission to improve womenโ€™s health outcomes globally. Molbioโ€™s track record of delivering innovative diagnostic solutions, including the WHO-endorsed Truenat PCR platform, positions the company as a strong partner to scale the reach of iBreastExam.

The collaboration will focus on rolling out the device across India, Africa, the Middle East, CIS countries, the Philippines, Indonesia, and Vietnam, creating new opportunities for early intervention and saving countless lives through timely diagnosis.

This partnership is not just about technologyโ€”it is about bridging gaps in access to healthcare, empowering women, and ensuring that early detection of breast cancer is no longer a privilege, but a global reality.

Health

Molbio Diagnostics Empowers Philippines to Fast-Track TB Elimination with Truenat and Ultra-Portable X-ray Tech


Tuberculosis (TB) continues to be one of the Philippinesโ€™ most pressing public health challenges, with nearly 190,000 cases going undetected each year. In a transformative move aligned with the UN goal to treat 2.1 million TB cases by 2027, the Philippines Department of Health has embraced Indian innovation to revolutionize its TB response.

At the forefront is the Truenatยฎ platform, a WHO-endorsed, ICMR-approved molecular diagnostic solution developed by Goa-based Molbio Diagnostics. Designed for portability, accuracy, and speed, the Truenatยฎ system supports rapid testing not just for TB, but for a wide array of infectious diseases, including HIV, HPV, and Hepatitis B & C.

Currently, 68 Truenatยฎ devices are operational across the Philippines. A pilot on Bantayan Island yielded a staggering 1008% increase in TB detection โ€” a powerful testament to the platformโ€™s impact.

Geographic barriers, under-resourced labs, and limited rural access have long hindered TB diagnosis in the Philippines. Truenatยฎ, alongside the newly approved PRORAD Atlas Ultraportable X-ray system, now makes it possible to deliver end-to-end screening, diagnosis, and treatment โ€” even in the most isolated communities.

During an official visit to Molbioโ€™s facility in India, Philippines Health Secretary Dr. Teodoro J Herbosa commended the partnership, calling it a โ€œbeacon of innovationโ€ and highlighting the broader strategic alliance between the two nations. โ€œTruenatยฎ allows for swift and accurate TB screenings, enhancing our capacity to manage and eventually eliminate TB within our borders,โ€ he said.

This healthcare collaboration reflects a growing Indo-Philippine partnership that now exceeds $3 billion in trade, spanning pharmaceuticals, medical technology, and beyond.

Molbio Diagnostics will further its engagement with the Philippines by hosting a panel at the 31st Philippine Coalition Against Tuberculosis (PhilCAT) Annual Convention in Manila on August 14โ€“15, 2025.

The companyโ€™s broader mission continues through projects like a multi-country R2D2 TB Network study exploring tongue-swab molecular testing โ€” a game-changer for TB detection among children and people with HIV/AIDS.

โ€œBy bringing diagnostics to the doorstep of underserved communities, we aim to close the TB care gap and help countries build stronger, more resilient health systems,โ€ said Shiva Sriram, President of Molbio Diagnostics.

Health

Augmented Reality Revolutionises Joint Replacement Surgery in Goa with Pixee Technology


In a transformative leap for orthopaedic care, Goa has successfully completed 50 joint replacement surgeries using Pixee, a revolutionary Augmented Reality (AR) surgical platform developed in France and introduced in India by global medtech leader Meril.

Spearheaded by Dr. Ameya Velingker and his team at Bone and Joint Care, this achievement marks Goaโ€™s entry into the future of surgical innovation.

Pixee is an AR-assisted surgical platform that provides real-time 3D anatomical visualisation during joint replacement procedures. It helps surgeons view exact internal anatomy and make highly precise incisions and alignments, reducing human error and improving the overall outcome of the surgery.

Using smart glasses and tracking systems, Pixee overlays real-time digital guides on the surgeonโ€™s field of view. This ensures:

  • Accurate bone alignment
  • Minimal tissue damage
  • Shorter surgery duration
  • Reduced post-op complications
  • Faster recovery for patients

โ€œIntegrating Pixee AR technology into our surgical practice has been a game-changer,โ€ said Dr. Ameya Velingker.
โ€œWeโ€™re now able to visualise patient anatomy in real time, make ultra-precise incisions, and complete procedures more efficiently. This means less blood loss, faster recovery, and better long-term outcomes for our patients.โ€

While the spotlight is currently on orthopaedics, AR is poised to transform multiple medical fields. Its applications in neurosurgery, oncology, and cardiology are expanding rapidly. Whether itโ€™s guiding a brain surgeon through a delicate procedure or helping an oncologist localise a tumour, ARโ€™s potential to improve safety and precision is unmatched.

This milestone places Goa at the forefront of healthcare innovation in India. Patients no longer need to travel to metropolitan cities for state-of-the-art care. With AR-powered procedures now available locally, Bone and Joint Care is reshaping how surgeries are experienced in the region.

As Bone and Joint Care continues to pioneer advancements in AR-assisted surgery, the future of minimally invasive, precise, and patient-focused care becomes a reality. This is just the beginning of how technology like Pixee is reshaping the surgical landscape โ€” one joint at a time.

Health

Manipal Hospital Goa Unveils VELYS Robotic System, Revolutionising Knee Replacement Surgery in the State


Goa, July 29, 2025 โ€“ In a landmark event for the stateโ€™s healthcare sector, Manipal Hospital Goa officially unveiled the Depuy VELYS Robotic-Assisted Solution, a cutting-edge innovation by Johnson & Johnson, aimed at revolutionising knee replacement procedures through precision and personalisation.

Held at the hospital premises, the launch event was graced by key dignitaries including Mr. Surendra Prasad, Hospital Director; Dr. Rohan R Desai, Consultant โ€“ Hip & Knee Replacement Surgeon; and Dr. Shereen Hasan Bhat, Medical Superintendent, alongside respected members of the medical fraternity.

Revolutionising Knee Replacement with VELYS

The VELYS Robotic-Assisted Solution is among the worldโ€™s most advanced tools for Total Knee Arthroplasty (TKA) and partial knee replacement. Unlike traditional systems, it integrates real-time intraoperative data to guide surgeons with pinpoint accuracyโ€”helping ensure optimal implant placement and alignment.

Compact, easy to use, and seamlessly integrated into operating rooms, VELYS is designed to work in conjunction with the ATTUNEยฎ Knee System. This collaboration enables outcomes with near 100% precision, offering:

  • Less post-operative pain
  • Shorter hospital stays
  • Faster recovery times
  • Quicker return to mobility

Leadership Voices the Vision

โ€œGoa deserves access to the best in healthcare,โ€ said Mr. Surendra Prasad. โ€œThe VELYS system equips our surgeons with unmatched accuracy and reinforces our commitment to advanced patient care.โ€

The launch included a traditional lamp-lighting ceremony, followed by the grand unveiling of the robotic system. Dr. Rohan R Desai gave an insightful walkthrough of VELYS’s capabilities, underscoring how the technology personalises surgery by adapting to each patientโ€™s unique anatomy and movement patterns.

โ€œWith VELYS, we can now deliver tailor-made solutions for every knee,โ€ Dr. Desai added. โ€œItโ€™s a game-changer for patients suffering from degenerative joint diseases.โ€

The event concluded with a Q&A session and a vote of thanks by Dr. Shereen Hasan Bhat, emphasizing the hospitalโ€™s continued dedication to innovation and excellence.

A Technological Leap for Goaโ€™s Healthcare Landscape

With this strategic addition, Manipal Hospital Goa cements its position as a front-runner in high-tech orthopaedic care. It reinforces Goaโ€™s emerging status as a regional healthcare hub, where local and international patients alike can access world-class treatment.

Fit & Fabulous

Celebrating a Week of Robotic Knee Replacement Surgeries at Manipal Hospital Goa


Goa, 25th February 2025 โ€“ Manipal Hospital Goa marks a successful week of advanced robotic knee replacement surgeries, revolutionizing patient care and recovery outcomes. Under the expert guidance of Dr. Rohan Dessai, Consultant Hip and Knee Replacement Surgeon at Manipal Hospital Goa, the hospital conducted six robotic-assisted total knee replacements over the past five days, benefiting patients with enhanced precision, faster recovery, and minimal post-operative discomfort.

The cutting-edge robotic system, which was stationed at the hospitalโ€™s operation theatre throughout the week, enabled Dr. Rohan Dessai to perform single and bilateral knee replacements with unparalleled accuracy. One of the key advantages of this robotic technology is its intra-operative precision, allowing up to 0.5-degree angular accuracy and 0.5mm adjustments while placing the femoral and tibial components. The technique ensures minimal soft tissue dissection, resulting in faster recovery, reduced pain, and minimal post-operative swelling.

All patients were made to walk within 3-4 hoursโ€™ post-surgery and discharged promptly. Patients undergoing single knee replacement were discharged within 24 hours, while a patient who underwent bilateral knee replacement was safely discharged within two days. Additionally, all procedures featured stitchless wound closure, promoting faster healing and zero infection rates.

Speaking about this milestone, Dr. Rohan Dessai shared, โ€œRobotic-assisted knee replacement surgery is a game changer in orthopedic care. The precision of this system, combined with minimal tissue handling, translates to quicker recovery and improved patient outcomes. We are delighted to offer this state-of-the-art technology at Manipal Hospital Goa and provide our patients with the best possible care.โ€
Echoing these sentiments, Mr. Surendra Prasad, Hospital Director, Manipal Hospital, Goa added, โ€œAt Manipal Hospital Goa, we continuously strive to integrate the latest advancements in medical technology to enhance patient care. The success of this weekโ€™s robotic knee replacement surgeries reflects our commitment to excellence in orthopedic surgery and patient-centered care.โ€
This landmark achievement underscores Manipal Hospital Goaโ€™s dedication to pioneering medical advancements, ensuring that patients receive the highest standard of orthopedic care with cutting-edge technology and expert hands.